Invivyd启动COVID预防抗体VYD2311的三期临床试验

康涅狄格州纽黑文 - Invivyd, Inc. (NASDAQ:IVVD) 周二宣布启动DECLARATION试验，以评估用于COVID-19预防的候选单克隆抗体VYD2311。这家生物技术公司目前市值约6.71亿美元，其股票今年以来已上涨超过550%，因为投资者看好其COVID-19预防管线。
China.org.cn

Roundup: Thai, Cambodian leaders holds phone talks with Trump on border conflict

BANGKOK/PHNOM PENH, Dec. 13 (Xinhua) -- Thailand's caretaker Prime Minister Anutin Charnvirakul and Cambodian Prime Minister Hun Manet said they held separate phone talks with U.S. President Donald ...